Abstract

For over 15 years, human subcutaneous adipose tissue has been recognized as a rich source of tissue resident mesenchymal stem/stromal cells (MSC). The isolation of perivascular progenitor cells from human adipose tissue by a cell sorting strategy was first published in 2008. Since this time, the interest in using pericytes and related perivascular stem/stromal cell (PSC) populations for tissue engineering has significantly increased. Here, we describe a set of experiments identifying, isolating and characterizing PSC from canine tissue (N = 12 canine adipose tissue samples). Results showed that the same antibodies used for human PSC identification and isolation are cross-reactive with canine tissue (CD45, CD146, CD34). Like their human correlate, canine PSC demonstrate characteristics of MSC including cell surface marker expression, colony forming unit-fibroblast (CFU-F) inclusion, and osteogenic differentiation potential. As well, canine PSC respond to osteoinductive signals in a similar fashion as do human PSC, such as the secreted differentiation factor NEL-Like Molecule-1 (NELL-1). Nevertheless, important differences exist between human and canine PSC, including differences in baseline osteogenic potential. In summary, canine PSC represent a multipotent mesenchymogenic cell source for future translational efforts in tissue engineering.

Highlights

  • Mesenchymal stem/stromal cells (MSC) are a multipotent cell population with multiple applications in bone tissue engineering, including promotion of wound repair[1] and tissue regeneration[2]

  • CD34+CD146− adventitial cells and CD146+CD34 − pericytes were isolated by fluorescence activated cell sorting (FACS) in an identical manner to those derived from human adipose tissue, collectively referred to as perivascular stem/ stromal cell (PSC)

  • The current study investigates canine PSC as a stem/stromal cell population for translational efforts in bone tissue engineering

Read more

Summary

Introduction

Mesenchymal stem/stromal cells (MSC) are a multipotent cell population with multiple applications in bone tissue engineering, including promotion of wound repair[1] and tissue regeneration[2]. Culture-derived MSC from both tissues are accompanied by significant drawbacks for bone tissue engineering. Bone marrow mesenchymal stem/stromal cells (BMSC) come with significant impediments for clinical translation, including low stem cell frequency, harvest site morbidity, and requirement for culture derivation. Adipose tissue is abundant, accessible and readily available by routine liposuction procedures with minimal donor site morbidity[3,4,5]. The cellular heterogeneity of the stromal vascular fraction (SVF) of adipose tissue is associated with reduced or unreliable bone forming efficacy[6, 7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call